Industry: Medical Devices & Consumables
Published Date: 2025-07-31
Pages: 184 Pages
Report ld: 4808012
Request Sample
Customized Report
In Vivo Imaging Systems Market Size(US$)

CAGR 2025-2031
3.1%
Market Size,2031
USD 169
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global In Vivo Imaging Systems market is projected to grow from US$ 137 million in 2024 to US$ 169 million by 2031, at a CAGR of 3.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Small animal living body imaging technology refers to the application of imaging methods to carry out qualitative and quantitative research on biological processes at the tissue, cell and molecular levels in the living state. In vivo imaging is one of the techniques for long-term longitudinal study of animals without damaging them. Imaging technology can provide absolute quantitative and relative quantitative data. It changes according to its position in the sample. This kind of technology provides absolute quantitative information, such as CT, MRI and pet; Image data signals are sample position dependent, such as bioluminescence, fluorescence and multiphoton microscopy in visible light imaging, which belong to the category of relative quantification, but can be quantified by strictly designing experiments.
Small animal in vivo imaging technology is a non-invasive method widely used in biomedical research, which can observe and track biological processes in small animals in real time. Through this technology, researchers can gain a deep understanding of dynamic changes such as disease progression, drug response and gene expression. Common in vivo imaging technologies include optical imaging, magnetic resonance imaging (MRI), positron emission tomography (PET), etc. This technology helps to reduce the use of experimental animals, provide more efficient and accurate experimental data, and promote the development of new drugs and the study of disease mechanisms. The main manufacturers of small animal in vivo imaging systems (In Vivo Imaging Systems) in the world include Perkin Elmer, Canon Medical Systems, Bruker, Idexx Laboratories and Hallmarq Veterinary Imaging, etc. The top five manufacturers account for about 47% of the global market share. In terms of revenue, North America is the largest market, accounting for about 64% of the market share. In terms of product type, optical imaging is the largest segment, accounting for about 65% of the revenue share, and in terms of downstream, laboratories are the largest downstream field, accounting for 78% of the revenue share. In the small animal in vivo imaging industry, manufacturers need to take multiple measures to promote technological innovation and enhance market competitiveness. First, manufacturers should focus on technology research and development, and continuously improve the resolution, sensitivity and multimodal functions of imaging equipment so that they can more accurately capture biological processes in small animals. In addition, manufacturers should focus on developing user-friendly software platforms to ensure the automation and simplicity of data acquisition and analysis to reduce the operational burden of researchers and improve experimental efficiency. Secondly, manufacturers should strengthen cooperation with scientific research institutions and pharmaceutical companies to meet the needs of different industries and fields through customized solutions. For example, in cutting-edge fields such as cancer research, new drug development and gene therapy, providing targeted imaging equipment and services can effectively expand the market. At the same time, manufacturers should also pay attention to the cost-effectiveness of equipment, while maintaining high-quality imaging performance, by optimizing production processes and supply chains, reducing the manufacturing cost of equipment, making in vivo imaging technology more economically feasible, and attracting more small and medium-sized laboratories to use it. In addition, with the increasing global attention to animal welfare, manufacturers also need to ensure that their equipment complies with ethical standards and regulations, reduce unnecessary harm to experimental animals, and provide more accurate non-invasive imaging technology to help researchers achieve more humane experimental design. Finally, manufacturers should establish a comprehensive after-sales service system to provide equipment maintenance, technical support and operation training to ensure that users can use the equipment in a long-term and stable manner. Through a comprehensive layout in technology, cooperation, cost, ethics and service, manufacturers can maintain a sustained competitive advantage in the small animal in vivo imaging industry, meet the growing needs of scientific researchers and pharmaceutical companies, and promote the advancement of biomedical research.
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global In Vivo Imaging Systems market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the In Vivo Imaging Systems study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to In Vivo Imaging Systems: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global In Vivo Imaging Systems Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Optical Imaging
1.2.3 MRI
1.2.4 Ultrasound
1.2.5 Others
1.3 Market Segmentation by Application
1.3.1 Global In Vivo Imaging Systems Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Laboratory
1.3.3 Pet Hospital and Clinic
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global In Vivo Imaging Systems Revenue Estimates and Forecasts 2020-2031
2.2 Global In Vivo Imaging Systems Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global In Vivo Imaging Systems Sales Estimates and Forecasts 2020-2031
2.4 Global In Vivo Imaging Systems Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global In Vivo Imaging Systems Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global In Vivo Imaging Systems Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Optical Imaging Market Size by Manufacturers
3.5.2 MRI Market Size by Manufacturers
3.5.3 Ultrasound Market Size by Manufacturers
3.5.4 Others Market Size by Manufacturers
3.6 Global In Vivo Imaging Systems Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global In Vivo Imaging Systems Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global In Vivo Imaging Systems Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global In Vivo Imaging Systems Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global In Vivo Imaging Systems Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America In Vivo Imaging Systems Sales and Revenue by Type (2020-2031)
6.4 North America In Vivo Imaging Systems Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America In Vivo Imaging Systems Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe In Vivo Imaging Systems Sales and Revenue by Type (2020-2031)
7.4 Europe In Vivo Imaging Systems Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe In Vivo Imaging Systems Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific In Vivo Imaging Systems Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific In Vivo Imaging Systems Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific In Vivo Imaging Systems Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America In Vivo Imaging Systems Sales and Revenue by Type (2020-2031)
9.4 Central and South America In Vivo Imaging Systems Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America In Vivo Imaging Systems Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa In Vivo Imaging Systems Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa In Vivo Imaging Systems Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa In Vivo Imaging Systems Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Perkin Elmer
11.1.1 Perkin Elmer Corporation Information
11.1.2 Perkin Elmer Business Overview
11.1.3 Perkin Elmer In Vivo Imaging Systems Product Models, Descriptions and Specifications
11.1.4 Perkin Elmer In Vivo Imaging Systems Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Perkin Elmer In Vivo Imaging Systems Sales by Product in 2024
11.1.6 Perkin Elmer In Vivo Imaging Systems Sales by Application in 2024
11.1.7 Perkin Elmer In Vivo Imaging Systems Sales by Geographic Area in 2024
11.1.8 Perkin Elmer In Vivo Imaging Systems SWOT Analysis
11.1.9 Perkin Elmer Recent Developments
11.2 Canon Medical Systems
11.2.1 Canon Medical Systems Corporation Information
11.2.2 Canon Medical Systems Business Overview
11.2.3 Canon Medical Systems In Vivo Imaging Systems Product Models, Descriptions and Specifications
11.2.4 Canon Medical Systems In Vivo Imaging Systems Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Canon Medical Systems In Vivo Imaging Systems Sales by Product in 2024
11.2.6 Canon Medical Systems In Vivo Imaging Systems Sales by Application in 2024
11.2.7 Canon Medical Systems In Vivo Imaging Systems Sales by Geographic Area in 2024
11.2.8 Canon Medical Systems In Vivo Imaging Systems SWOT Analysis
11.2.9 Canon Medical Systems Recent Developments
11.3 Bruker
11.3.1 Bruker Corporation Information
11.3.2 Bruker Business Overview
11.3.3 Bruker In Vivo Imaging Systems Product Models, Descriptions and Specifications
11.3.4 Bruker In Vivo Imaging Systems Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Bruker In Vivo Imaging Systems Sales by Product in 2024
11.3.6 Bruker In Vivo Imaging Systems Sales by Application in 2024
11.3.7 Bruker In Vivo Imaging Systems Sales by Geographic Area in 2024
11.3.8 Bruker In Vivo Imaging Systems SWOT Analysis
11.3.9 Bruker Recent Developments
11.4 Idexx Laboratories
11.4.1 Idexx Laboratories Corporation Information
11.4.2 Idexx Laboratories Business Overview
11.4.3 Idexx Laboratories In Vivo Imaging Systems Product Models, Descriptions and Specifications
11.4.4 Idexx Laboratories In Vivo Imaging Systems Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Idexx Laboratories In Vivo Imaging Systems Sales by Product in 2024
11.4.6 Idexx Laboratories In Vivo Imaging Systems Sales by Application in 2024
11.4.7 Idexx Laboratories In Vivo Imaging Systems Sales by Geographic Area in 2024
11.4.8 Idexx Laboratories In Vivo Imaging Systems SWOT Analysis
11.4.9 Idexx Laboratories Recent Developments
11.5 Hallmarq Veterinary Imaging
11.5.1 Hallmarq Veterinary Imaging Corporation Information
11.5.2 Hallmarq Veterinary Imaging Business Overview
11.5.3 Hallmarq Veterinary Imaging In Vivo Imaging Systems Product Models, Descriptions and Specifications
11.5.4 Hallmarq Veterinary Imaging In Vivo Imaging Systems Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Hallmarq Veterinary Imaging In Vivo Imaging Systems Sales by Product in 2024
11.5.6 Hallmarq Veterinary Imaging In Vivo Imaging Systems Sales by Application in 2024
11.5.7 Hallmarq Veterinary Imaging In Vivo Imaging Systems Sales by Geographic Area in 2024
11.5.8 Hallmarq Veterinary Imaging In Vivo Imaging Systems SWOT Analysis
11.5.9 Hallmarq Veterinary Imaging Recent Developments
11.6 Huantong Nuclear Magnet
11.6.1 Huantong Nuclear Magnet Corporation Information
11.6.2 Huantong Nuclear Magnet Business Overview
11.6.3 Huantong Nuclear Magnet In Vivo Imaging Systems Product Models, Descriptions and Specifications
11.6.4 Huantong Nuclear Magnet In Vivo Imaging Systems Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Huantong Nuclear Magnet Recent Developments
11.7 Sunny Optical
11.7.1 Sunny Optical Corporation Information
11.7.2 Sunny Optical Business Overview
11.7.3 Sunny Optical In Vivo Imaging Systems Product Models, Descriptions and Specifications
11.7.4 Sunny Optical In Vivo Imaging Systems Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Sunny Optical Recent Developments
11.8 Photon
11.8.1 Photon Corporation Information
11.8.2 Photon Business Overview
11.8.3 Photon In Vivo Imaging Systems Product Models, Descriptions and Specifications
11.8.4 Photon In Vivo Imaging Systems Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Photon Recent Developments
11.9 MILABS
11.9.1 MILABS Corporation Information
11.9.2 MILABS Business Overview
11.9.3 MILABS In Vivo Imaging Systems Product Models, Descriptions and Specifications
11.9.4 MILABS In Vivo Imaging Systems Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 MILABS Recent Developments
11.10 iThera Medical
11.10.1 iThera Medical Corporation Information
11.10.2 iThera Medical Business Overview
11.10.3 iThera Medical In Vivo Imaging Systems Product Models, Descriptions and Specifications
11.10.4 iThera Medical In Vivo Imaging Systems Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 iThera Medical Recent Developments
11.11 Vieworks
11.11.1 Vieworks Corporation Information
11.11.2 Vieworks Business Overview
11.11.3 Vieworks In Vivo Imaging Systems Product Models, Descriptions and Specifications
11.11.4 Vieworks In Vivo Imaging Systems Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Vieworks Recent Developments
11.12 Aspect Imaging
11.12.1 Aspect Imaging Corporation Information
11.12.2 Aspect Imaging Business Overview
11.12.3 Aspect Imaging In Vivo Imaging Systems Product Models, Descriptions and Specifications
11.12.4 Aspect Imaging In Vivo Imaging Systems Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 Aspect Imaging Recent Developments
11.13 TOMOWAVE
11.13.1 TOMOWAVE Corporation Information
11.13.2 TOMOWAVE Business Overview
11.13.3 TOMOWAVE In Vivo Imaging Systems Product Models, Descriptions and Specifications
11.13.4 TOMOWAVE In Vivo Imaging Systems Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 TOMOWAVE Recent Developments
11.14 Trifoil Imaging
11.14.1 Trifoil Imaging Corporation Information
11.14.2 Trifoil Imaging Business Overview
11.14.3 Trifoil Imaging In Vivo Imaging Systems Product Models, Descriptions and Specifications
11.14.4 Trifoil Imaging In Vivo Imaging Systems Sales, Price, Revenue and Gross Margin (2020-2025)
11.14.5 Trifoil Imaging Recent Developments
11.15 Clinx
11.15.1 Clinx Corporation Information
11.15.2 Clinx Business Overview
11.15.3 Clinx In Vivo Imaging Systems Product Models, Descriptions and Specifications
11.15.4 Clinx In Vivo Imaging Systems Sales, Price, Revenue and Gross Margin (2020-2025)
11.15.5 Clinx Recent Developments
11.16 Raylight
11.16.1 Raylight Corporation Information
11.16.2 Raylight Business Overview
11.16.3 Raylight In Vivo Imaging Systems Product Models, Descriptions and Specifications
11.16.4 Raylight In Vivo Imaging Systems Sales, Price, Revenue and Gross Margin (2020-2025)
11.16.5 Raylight Recent Developments
11.17 Spectral Instruments Imaging
11.17.1 Spectral Instruments Imaging Corporation Information
11.17.2 Spectral Instruments Imaging Business Overview
11.17.3 Spectral Instruments Imaging In Vivo Imaging Systems Product Models, Descriptions and Specifications
11.17.4 Spectral Instruments Imaging In Vivo Imaging Systems Sales, Price, Revenue and Gross Margin (2020-2025)
11.17.5 Spectral Instruments Imaging Recent Developments
11.18 Novel Medical
11.18.1 Novel Medical Corporation Information
11.18.2 Novel Medical Business Overview
11.18.3 Novel Medical In Vivo Imaging Systems Product Models, Descriptions and Specifications
11.18.4 Novel Medical In Vivo Imaging Systems Sales, Price, Revenue and Gross Margin (2020-2025)
11.18.5 Novel Medical Recent Developments
11.19 Tanon
11.19.1 Tanon Corporation Information
11.19.2 Tanon Business Overview
11.19.3 Tanon In Vivo Imaging Systems Product Models, Descriptions and Specifications
11.19.4 Tanon In Vivo Imaging Systems Sales, Price, Revenue and Gross Margin (2020-2025)
11.19.5 Tanon Recent Developments
11.20 Biolight
11.20.1 Biolight Corporation Information
11.20.2 Biolight Business Overview
11.20.3 Biolight In Vivo Imaging Systems Product Models, Descriptions and Specifications
11.20.4 Biolight In Vivo Imaging Systems Sales, Price, Revenue and Gross Margin (2020-2025)
11.20.5 Biolight Recent Developments
11.21 PINGSENG Healthcare
11.21.1 PINGSENG Healthcare Corporation Information
11.21.2 PINGSENG Healthcare Business Overview
11.21.3 PINGSENG Healthcare In Vivo Imaging Systems Product Models, Descriptions and Specifications
11.21.4 PINGSENG Healthcare In Vivo Imaging Systems Sales, Price, Revenue and Gross Margin (2020-2025)
11.21.5 PINGSENG Healthcare Recent Developments
11.22 Fujifilm Visualsonics
11.22.1 Fujifilm Visualsonics Corporation Information
11.22.2 Fujifilm Visualsonics Business Overview
11.22.3 Fujifilm Visualsonics In Vivo Imaging Systems Product Models, Descriptions and Specifications
11.22.4 Fujifilm Visualsonics In Vivo Imaging Systems Sales, Price, Revenue and Gross Margin (2020-2025)
11.22.5 Fujifilm Visualsonics Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 In Vivo Imaging Systems Industry Chain
12.2 In Vivo Imaging Systems Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 In Vivo Imaging Systems Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 In Vivo Imaging Systems Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 In Vivo Imaging Systems Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global In Vivo Imaging Systems Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global In Vivo Imaging Systems market size was US$ 141 million in 2025 and is forecast to reach a readjusted size of US$ 174 million by 2032 with a CAGR of 3.1% during the forecast period 2026-2032.
Published Date: 2026-01-05
Pages: 119
USD 4250.00
(Single User License)
The global In Vivo Imaging Systems market was valued at US$ 141 million in 2025 and is anticipated to reach US$ 174 million by 2032, at a CAGR of 3.1% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 146
USD 2900.00
(Single User License)
The global market for In Vivo Imaging Systems was estimated to be worth US$ 141 million in 2025 and is projected to reach US$ 174 million, growing at a CAGR of 3.1% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 165
USD 3950.00
(Single User License)
The global In Vivo Imaging Systems market size was US$ 137 million in 2024 and is forecast to a readjusted size of US$ 169 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published Date: 2025-09-10
Pages: 116
USD 4250.00
(Single User License)
The global market for In Vivo Imaging Systems was estimated to be worth US$ 137 million in 2024 and is forecast to a readjusted size of US$ 169 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published Date: 2025-01-19
Pages: 157
USD 3950.00
(Single User License)
The global market for In Vivo Imaging Systems was valued at US$ 137 million in the year 2024 and is projected to reach a revised size of US$ 169 million by 2031, growing at a CAGR of 3.1% during the forecast period.
Published Date: 2025-01-19
Pages: 111
USD 2900.00
(Single User License)
Small animal living body imaging technology refers to the application of imaging methods to carry out qualitative and quantitative research on biological processes at the tissue, cell and molecular levels in the living state. In vivo imaging is one of the techniques for long-term longitudinal study of animals without damaging them. Imaging technology can provide absolute quantitative and relative quantitative data. It changes according to its position in the sample. This kind of technology provides absolute quantitative information, such as CT, MRI and pet; Image data signals are sample position dependent, such as bioluminescence, fluorescence and multiphoton microscopy in visible light imaging, which belong to the category of relative quantification, but can be quantified by strictly designing experiments.
Published Date: 2024-09-08
Pages: 174
USD 4350.00
(Single User License)
Small animal living body imaging technology refers to the application of imaging methods to carry out qualitative and quantitative research on biological processes at the tissue, cell and molecular levels in the living state. In vivo imaging is one of the techniques for long-term longitudinal study of animals without damaging them. Imaging technology can provide absolute quantitative and relative quantitative data. It changes according to its position in the sample. This kind of technology provides absolute quantitative information, such as CT, MRI and pet; Image data signals are sample position dependent, such as bioluminescence, fluorescence and multiphoton microscopy in visible light imaging, which belong to the category of relative quantification, but can be quantified by strictly designing experiments.
Published Date: 2024-09-08
Pages: 160
USD 3950.00
(Single User License)
Small animal living body imaging technology refers to the application of imaging methods to carry out qualitative and quantitative research on biological processes at the tissue, cell and molecular levels in the living state. In vivo imaging is one of the techniques for long-term longitudinal study of animals without damaging them. Imaging technology can provide absolute quantitative and relative quantitative data. It changes according to its position in the sample. This kind of technology provides absolute quantitative information, such as CT, MRI and pet; Image data signals are sample position dependent, such as bioluminescence, fluorescence and multiphoton microscopy in visible light imaging, which belong to the category of relative quantification, but can be quantified by strictly designing experiments.
Published Date: 2024-09-08
Pages: 190
USD 4900.00
(Single User License)
Small animal living body imaging technology refers to the application of imaging methods to carry out qualitative and quantitative research on biological processes at the tissue, cell and molecular levels in the living state. In vivo imaging is one of the techniques for long-term longitudinal study of animals without damaging them. Imaging technology can provide absolute quantitative and relative quantitative data. It changes according to its position in the sample. This kind of technology provides absolute quantitative information, such as CT, MRI and pet; Image data signals are sample position dependent, such as bioluminescence, fluorescence and multiphoton microscopy in visible light imaging, which belong to the category of relative quantification, but can be quantified by strictly designing experiments.
Published Date: 2024-09-08
Pages: 116
USD 2900.00
(Single User License)
The global In Vivo Imaging Systems market size was US$ 141 million in 2025 and is forecast to reach a readjusted size of US$ 174 million by 2032 with a CAGR of 3.1% during the forecast period 2026-2032.
Published: 2026-01-05
Pages: 119
The global In Vivo Imaging Systems market was valued at US$ 141 million in 2025 and is anticipated to reach US$ 174 million by 2032, at a CAGR of 3.1% from 2026 to 2032.
Published: 2026-01-05
Pages: 146
The global market for In Vivo Imaging Systems was estimated to be worth US$ 141 million in 2025 and is projected to reach US$ 174 million, growing at a CAGR of 3.1% from 2026 to 2032.
Published: 2026-01-05
Pages: 165
The global In Vivo Imaging Systems market size was US$ 137 million in 2024 and is forecast to a readjusted size of US$ 169 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published: 2025-09-10
Pages: 116
The global market for In Vivo Imaging Systems was estimated to be worth US$ 137 million in 2024 and is forecast to a readjusted size of US$ 169 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published: 2025-01-19
Pages: 157
The global market for In Vivo Imaging Systems was valued at US$ 137 million in the year 2024 and is projected to reach a revised size of US$ 169 million by 2031, growing at a CAGR of 3.1% during the forecast period.
Published: 2025-01-19
Pages: 111
Small animal living body imaging technology refers to the application of imaging methods to carry out qualitative and quantitative research on biological processes at the tissue, cell and molecular levels in the living state. In vivo imaging is one of the techniques for long-term longitudinal study of animals without damaging them. Imaging technology can provide absolute quantitative and relative quantitative data. It changes according to its position in the sample. This kind of technology provides absolute quantitative information, such as CT, MRI and pet; Image data signals are sample position dependent, such as bioluminescence, fluorescence and multiphoton microscopy in visible light imaging, which belong to the category of relative quantification, but can be quantified by strictly designing experiments.
Published: 2024-09-08
Pages: 174
Small animal living body imaging technology refers to the application of imaging methods to carry out qualitative and quantitative research on biological processes at the tissue, cell and molecular levels in the living state. In vivo imaging is one of the techniques for long-term longitudinal study of animals without damaging them. Imaging technology can provide absolute quantitative and relative quantitative data. It changes according to its position in the sample. This kind of technology provides absolute quantitative information, such as CT, MRI and pet; Image data signals are sample position dependent, such as bioluminescence, fluorescence and multiphoton microscopy in visible light imaging, which belong to the category of relative quantification, but can be quantified by strictly designing experiments.
Published: 2024-09-08
Pages: 160
Small animal living body imaging technology refers to the application of imaging methods to carry out qualitative and quantitative research on biological processes at the tissue, cell and molecular levels in the living state. In vivo imaging is one of the techniques for long-term longitudinal study of animals without damaging them. Imaging technology can provide absolute quantitative and relative quantitative data. It changes according to its position in the sample. This kind of technology provides absolute quantitative information, such as CT, MRI and pet; Image data signals are sample position dependent, such as bioluminescence, fluorescence and multiphoton microscopy in visible light imaging, which belong to the category of relative quantification, but can be quantified by strictly designing experiments.
Published: 2024-09-08
Pages: 190
Small animal living body imaging technology refers to the application of imaging methods to carry out qualitative and quantitative research on biological processes at the tissue, cell and molecular levels in the living state. In vivo imaging is one of the techniques for long-term longitudinal study of animals without damaging them. Imaging technology can provide absolute quantitative and relative quantitative data. It changes according to its position in the sample. This kind of technology provides absolute quantitative information, such as CT, MRI and pet; Image data signals are sample position dependent, such as bioluminescence, fluorescence and multiphoton microscopy in visible light imaging, which belong to the category of relative quantification, but can be quantified by strictly designing experiments.
Published: 2024-09-08
Pages: 116
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now